Solco Healthcare US LLC
Franklin Township, NJ Solco Healthcare US, LLC
- UEI
- JN2QZJD6PKM9
- CAGE
- 0JQ27
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 700 Atrium Dr a, Somerset, NJ 08873, USA
- Website
- solcohealthcare.com
- Founded
- 2004
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
About Solco Healthcare US LLC
Solco Healthcare US LLC, a foreign-owned for-profit pharmaceutical manufacturer headquartered in Somerset, New Jersey, supplies branded generic pharmaceutical tablets to the Department of Veterans Affairs as a prime contractor under single-award indefinite-delivery contracts with no set-asides.
The vendor operates exclusively in pharmaceutical preparation manufacturing (NAICS 325412, PSC 6505 — Drugs and Biologicals) and has secured three single-award IDCs through the VA National Acquisition Center's Pharmaceutical Prime Vendor Programs, which distribute products to the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The three awards span distinct pharmaceutical products: a $12.94 million contract for Tadalafil Tablets (awarded April 21, 2025, with ordering period through April 20, 2026, plus four one-year renewal options extending to April 20, 2027); a $5.95 million contract for Aripiprazole Tablets (awarded February 1, 2026, with base year ordering through January 31, 2027, plus four one-year options); and an $8.55 million contract for Ropinirole HCL Tablets (awarded September 28, 2026, with ordering period through September 27, 2027, plus four one-year options extending through 2030). All three contracts are commercial item acquisitions under FAR Part 12 with estimated annual requirements ranging from approximately 176,000 bottles (Ropinirole) across multiple dosage strengths and package configurations (100 or 500 tablets per bottle).
Customer concentration is total: 100% of awards fund VA National Acquisition Center programs, which represent the vendor's sole federal customer across the source data. Activity remains nascent — one award in 2025 and two in 2026 — with no subcontractor engagement. The three contracts collectively represent $27.4 million in combined potential value, all held as prime awards with no sub-award activity in the source.
Quick answers
What is Solco Healthcare US LLC's UEI?
Solco Healthcare US LLC's Unique Entity ID (UEI) in SAM.gov is JN2QZJD6PKM9.
What is Solco Healthcare US LLC's CAGE code?
Solco Healthcare US LLC's CAGE code is 0JQ27.
What is Solco Healthcare US LLC's primary NAICS code?
Solco Healthcare US LLC's primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).
Where is Solco Healthcare US LLC located?
Solco Healthcare US LLC's physical address in SAM.gov is 700 Atrium Dr a, Somerset, NJ 08873, USA.
Is Solco Healthcare US LLC registered in SAM.gov?
Yes. Solco Healthcare US LLC's SAM.gov registration is active through April 16, 2027.
On GovTribe
See Solco Healthcare US LLC's full federal record
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors